{"DataElement":{"publicId":"3227860","version":"1","preferredName":"Patient Brain Metastasis Clinical Trial Eligibility Criteria Ind-2","preferredDefinition":"the yes/no indicator related to the spread of cancer to the brain as an element of eligibility which is necessary to allow an individual to participate in a specific clinical trial.","longName":"3227859v1.0:2018257v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3227859","version":"1","preferredName":"Patient Brain Metastasis Clinical Trial Eligibility Criteria","preferredDefinition":"information related to an issue regarding spread of cancer that first appeared in the brain as an element of the personal medical history which is necessary to allow an individual to participate in a specific clinical trial.","longName":"2177068v1.0:3227857v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3227857","version":"1","preferredName":"Brain Metastasis Clinical Trial Eligibility Criteria","preferredDefinition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.:Cancer that has spread from the organ in which it first appeared to another organ. For example, breast cancer cells may spread (metastasize) to the lungs and cause the growth of a new tumor. When this happens, the disease is called metastatic breast cancer.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C12439:C19151:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain","conceptCode":"C12439","definition":"An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metastasis","conceptCode":"C19151","definition":"The spread or migration of cancer cells from one part of the body (the organ in which it first appeared) to another. The secondary tumor contains cells that are like those in the original (primary) tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0E56DCF-62B7-2E85-E040-BB89AD435FEB","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-04-14","modifiedBy":"ONEDATA","dateModified":"2011-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0E56DCF-62C8-2E85-E040-BB89AD435FEB","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-04-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6147165","version":"1","longName":"Wake Forest Baptist Medical Center","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6147167","version":"1","longName":"WFB","context":"NCIP"}]}],"AlternateNames":[{"name":"BRAIN_MET_ELIG_IND","type":"OID, CCTG","context":"CCTG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"3227859v1.0:2018257v1.0","type":"USED_BY","context":"CCTG"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Planning MRI confirmed zero, one, two, or three unresected lesions. Each unresected lesion must measure <3.0 cm in maximal extent on the contrasted planning MRI brain scan","url":null,"context":"CTEP"},{"name":"Pathology from the resected b","type":"Preferred Question Text","description":"Pathology from the resected brain metastasis must be consistent with a non-central nervous system primary site","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Post-operative MRI confirmed zero, one, two, or three unresected lesions. Each unresected lesion must measure <=3.0 cm in maximal extent on the contrasted post-operative MRI brain scan.","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Post-operative MRI confirmed zero, one, two, or three unresected lesions.  Each unresected lesion must measure <3.0 cm in maximal extent on the contrasted post-operative MRI brain scan.","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Post-operative MRI (or CT) scan confirmed zero, one, two, or three unresected lesions.  Each unresected lesion must measure <=3.0 cm in maximal extent on the contrasted post-operative MRI (or CT) brain scan.","url":null,"context":"CTEP"},{"name":"CE7","type":"Alternate Question Text","description":"Does the patient have a brain metastasis that is located less than or equal to 5mm of the optic chiasm or within the brainstem?","url":null,"context":"CCTG"},{"name":"CE7-2","type":"Alternate Question Text","description":"Does the patient have a brain metastasis that is located less than or equal to 5mm of the optic chiasm or either optic nerve?","url":null,"context":"CCTG"},{"name":"WF-1806","type":"Alternate Question Text","description":"No untreated brain metastases. Patients with treated brain metastases are eligible.","url":null,"context":"NCIP"},{"name":"NRG CRF_Text 1","type":"Alternate Question Text","description":"Brain","url":null,"context":"NRG"},{"name":"NRG CRF_Text 2","type":"Alternate Question Text","description":"Are all brain metastases located greater than 5 mm from the optic chiasm and outside the brainstem?","url":null,"context":"NRG"},{"name":"WF-1","type":"Alternate Question Text","description":"A brain metastasis that is 5 mm or less from the optic chiasm or optic nerves.","url":null,"context":"NCIP"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"BMV greater than or equal to 4 brain metastases per year at time of any SRS prior to enrollment.","url":null,"context":"NRG"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A0E56DCF-62DA-2E85-E040-BB89AD435FEB","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-04-14","modifiedBy":"TSESU","dateModified":"2023-05-04","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}